Selected Cell
Cell:
Value:
Pcitri.ignored_ids.dumb.final.p
Sheet3
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
4401
4402
4403
4404
4405
4406
4407
4408
4409
4410
4411
4412
4413
4414
4415
4416
4417
4418
4419
4420
4421
4422
4423
4424
4425
4426
4427
4428
4429
4430
4431
4432
4433
4434
4435
4436
4437
4438
4439
4440
4441
4442
4443
4444
4445
4446
4447
4448
4449
4450
4451
4452
4453
4454
4455
4456
4457
4458
4459
4460
4461
4462
4463
4464
4465
4466
4467
4468
4469
4470
4471
4472
4473
4474
4475
4476
4477
4478
4479
4480
4481
4482
4483
4484
4485
4486
4487
4488
4489
4490
4491
4492
4493
4494
4495
4496
4497
4498
4499
4500
4501
4502
4503
4504
4505
4506
4507
4508
4509
4510
4511
4512
4513
4514
4515
4516
4517
4518
4519
4520
4521
4522
4523
4524
4525
4526
4527
4528
4529
4530
4531
4532
4533
4534
4535
4536
4537
4538
4539
4540
4541
4542
4543
4544
4545
4546
4547
4548
4549
4550
4551
4552
4553
4554
4555
4556
4557
4558
4559
4560
4561
4562
4563
4564
4565
4566
4567
4568
4569
4570
4571
4572
4573
4574
4575
4576
4577
4578
4579
4580
4581
4582
4583
4584
4585
4586
4587
4588
4589
4590
4591
4592
4593
4594
4595
4596
4597
4598
4599
4600
| UnnamedSample_HQ_transcript/5801|m.2461 | UnnamedSample_HQ_transcript/5801 | Coverage 0.913 too low. | c2fde09c16ea879f4f39171b7587ddf2 | 1249 | Pfam | PF08623 | TATA-binding protein interacting (TIP20) | 1056 | 1219 | 1.6E-62 | T | 22-09-2020 | IPR013932 | TATA-binding protein interacting (TIP20) |
| UnnamedSample_HQ_transcript/96237|m.22130 | UnnamedSample_HQ_transcript/96237 | Coverage 0.271 too low. | 661b4700b06fff8549e94ca8606dbb48 | 208 | Pfam | PF08612 | TATA-binding related factor (TRF) of subunit 20 of Mediator complex | 1 | 196 | 2.0E-38 | T | 22-09-2020 | IPR013921 | Mediator complex, subunit Med20 |
| UnnamedSample_HQ_transcript/113345|m.24224 | UnnamedSample_HQ_transcript/113345 | Coverage 0.406 too low. | 661b4700b06fff8549e94ca8606dbb48 | 208 | Pfam | PF08612 | TATA-binding related factor (TRF) of subunit 20 of Mediator complex | 1 | 196 | 2.0E-38 | T | 22-09-2020 | IPR013921 | Mediator complex, subunit Med20 |
| UnnamedSample_HQ_transcript/106850|m.23436 | UnnamedSample_HQ_transcript/106850 | Coverage 0.317 too low. | 661b4700b06fff8549e94ca8606dbb48 | 208 | Pfam | PF08612 | TATA-binding related factor (TRF) of subunit 20 of Mediator complex | 1 | 196 | 2.0E-38 | T | 22-09-2020 | IPR013921 | Mediator complex, subunit Med20 |
| UnnamedSample_HQ_transcript/101960|m.22864 | UnnamedSample_HQ_transcript/101960 | Coverage 0.195 too low. | 661b4700b06fff8549e94ca8606dbb48 | 208 | Pfam | PF08612 | TATA-binding related factor (TRF) of subunit 20 of Mediator complex | 1 | 196 | 2.0E-38 | T | 22-09-2020 | IPR013921 | Mediator complex, subunit Med20 |
| UnnamedSample_HQ_transcript/9518|m.3679 | UnnamedSample_HQ_transcript/9518 | Coverage 0.881 too low. | a6817c9848c796f443a378f953222075 | 644 | Pfam | PF13927 | Immunoglobulin domain | 244 | 304 | 3.2E-8 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/9518|m.3679 | UnnamedSample_HQ_transcript/9518 | Coverage 0.881 too low. | a6817c9848c796f443a378f953222075 | 644 | Pfam | PF08205 | CD80-like C2-set immunoglobulin domain | 138 | 217 | 4.9E-13 | T | 22-09-2020 | IPR013162 | CD80-like, immunoglobulin C2-set |
| UnnamedSample_HQ_transcript/9518|m.3679 | UnnamedSample_HQ_transcript/9518 | Coverage 0.881 too low. | a6817c9848c796f443a378f953222075 | 644 | Pfam | PF07679 | Immunoglobulin I-set domain | 339 | 405 | 2.0E-10 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/65570|m.17124 | UnnamedSample_HQ_transcript/65570 | Coverage 0.952 too low. | 21f92141a0ca76717e3c64c47c8b1ac0 | 528 | Pfam | PF00651 | BTB/POZ domain | 349 | 454 | 1.6E-18 | T | 22-09-2020 | IPR000210 | BTB/POZ domain |
| UnnamedSample_HQ_transcript/15270|m.5487 | UnnamedSample_HQ_transcript/15270 | Identity 0.922 too low. | 5ec85ddf79d43d55e0349f11c70a970f | 979 | Pfam | PF01044 | Vinculin family | 3 | 977 | 0 | T | 22-09-2020 | IPR006077 | Vinculin/alpha-catenin |
| UnnamedSample_HQ_transcript/61394|m.16337 | UnnamedSample_HQ_transcript/61394 | Coverage 0.326 too low. | e27fcb2001daeda14b9be1f3d8b44368 | 439 | Pfam | PF01770 | Reduced folate carrier | 6 | 396 | 1.5E-16 | T | 22-09-2020 | IPR002666 | Reduced folate carrier |
| UnnamedSample_HQ_transcript/4535|m.2011 | UnnamedSample_HQ_transcript/4535 | Coverage 0.975 too low. | 41556bab7543ab3f5f8fae9c8abdc12b | 1601 | Pfam | PF01751 | Toprim domain | 424 | 525 | 9.5E-8 | T | 22-09-2020 | IPR006171 | TOPRIM domain |
| UnnamedSample_HQ_transcript/4535|m.2011 | UnnamedSample_HQ_transcript/4535 | Coverage 0.975 too low. | 41556bab7543ab3f5f8fae9c8abdc12b | 1601 | Pfam | PF02518 | Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase | 48 | 192 | 1.9E-15 | T | 22-09-2020 | IPR003594 | Histidine kinase/HSP90-like ATPase |
| UnnamedSample_HQ_transcript/4535|m.2011 | UnnamedSample_HQ_transcript/4535 | Coverage 0.975 too low. | 41556bab7543ab3f5f8fae9c8abdc12b | 1601 | Pfam | PF00204 | DNA gyrase B | 235 | 395 | 8.9E-26 | T | 22-09-2020 | IPR013506 | DNA topoisomerase, type IIA, subunit B, domain 2 |
| UnnamedSample_HQ_transcript/4535|m.2011 | UnnamedSample_HQ_transcript/4535 | Coverage 0.975 too low. | 41556bab7543ab3f5f8fae9c8abdc12b | 1601 | Pfam | PF16898 | C-terminal associated domain of TOPRIM | 540 | 683 | 1.2E-47 | T | 22-09-2020 | IPR031660 | C-terminal associated domain of TOPRIM |
| UnnamedSample_HQ_transcript/4535|m.2011 | UnnamedSample_HQ_transcript/4535 | Coverage 0.975 too low. | 41556bab7543ab3f5f8fae9c8abdc12b | 1601 | Pfam | PF00521 | DNA gyrase/topoisomerase IV, subunit A | 685 | 1159 | 9.9E-129 | T | 22-09-2020 | IPR002205 | DNA topoisomerase, type IIA, subunit A/C-terminal |
| UnnamedSample_HQ_transcript/16103|m.5742 | UnnamedSample_HQ_transcript/16103 | Identity 0.877 too low. | ed53d4efde7b28776191259192c6809a | 111 | Pfam | PF03271 | EB1-like C-terminal motif | 52 | 88 | 3.4E-18 | T | 22-09-2020 | IPR004953 | EB1, C-terminal |
| UnnamedSample_HQ_transcript/98945|m.22486 | UnnamedSample_HQ_transcript/98945 | Unmapped. | 517d053c937bbc6db6f8dfd510ec09ee | 332 | Pfam | PF08512 | Histone chaperone Rttp106-like | 57 | 137 | 6.5E-19 | T | 22-09-2020 | IPR013719 | Domain of unknown function DUF1747 |
| UnnamedSample_HQ_transcript/114279|m.24318 | UnnamedSample_HQ_transcript/114279 | Coverage 0.953 too low. | 4c2d20f468c93a3be5eafbba283fcfd1 | 217 | Pfam | PF07679 | Immunoglobulin I-set domain | 93 | 180 | 2.2E-9 | T | 22-09-2020 | IPR013098 | Immunoglobulin I-set |
| UnnamedSample_HQ_transcript/20511|m.7011 | UnnamedSample_HQ_transcript/20511 | Coverage 0.037 too low. | 0ce053566bf6b0edad2a9066d939e535 | 708 | Pfam | PF02138 | Beige/BEACH domain | 50 | 326 | 1.1E-120 | T | 22-09-2020 | IPR000409 | BEACH domain |
| UnnamedSample_HQ_transcript/20511|m.7011 | UnnamedSample_HQ_transcript/20511 | Coverage 0.037 too low. | 0ce053566bf6b0edad2a9066d939e535 | 708 | Pfam | PF00400 | WD domain, G-beta repeat | 621 | 651 | 0.044 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/20511|m.7011 | UnnamedSample_HQ_transcript/20511 | Coverage 0.037 too low. | 0ce053566bf6b0edad2a9066d939e535 | 708 | Pfam | PF00400 | WD domain, G-beta repeat | 480 | 516 | 0.016 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/12733|m.4736 | UnnamedSample_HQ_transcript/12733 | Coverage 0.606 too low. | f664c276b900bf16f0fda039ac246b59 | 853 | Pfam | PF00571 | CBS domain | 596 | 642 | 1.9E-5 | T | 22-09-2020 | IPR000644 | CBS domain |
| UnnamedSample_HQ_transcript/12733|m.4736 | UnnamedSample_HQ_transcript/12733 | Coverage 0.606 too low. | f664c276b900bf16f0fda039ac246b59 | 853 | Pfam | PF00571 | CBS domain | 742 | 789 | 1.6E-9 | T | 22-09-2020 | IPR000644 | CBS domain |
| UnnamedSample_HQ_transcript/12733|m.4736 | UnnamedSample_HQ_transcript/12733 | Coverage 0.606 too low. | f664c276b900bf16f0fda039ac246b59 | 853 | Pfam | PF00571 | CBS domain | 669 | 715 | 9.5E-7 | T | 22-09-2020 | IPR000644 | CBS domain |
| UnnamedSample_HQ_transcript/18271|m.6385 | UnnamedSample_HQ_transcript/18271 | Coverage 0.144 too low. | 0b892fb1ccd17911b83dc31bed96a5f8 | 620 | Pfam | PF00567 | Tudor domain | 11 | 76 | 2.7E-13 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/18271|m.6385 | UnnamedSample_HQ_transcript/18271 | Coverage 0.144 too low. | 0b892fb1ccd17911b83dc31bed96a5f8 | 620 | Pfam | PF00567 | Tudor domain | 146 | 249 | 2.7E-14 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/18271|m.6385 | UnnamedSample_HQ_transcript/18271 | Coverage 0.144 too low. | 0b892fb1ccd17911b83dc31bed96a5f8 | 620 | Pfam | PF00567 | Tudor domain | 317 | 429 | 2.3E-23 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/49576|m.13927 | UnnamedSample_HQ_transcript/49576 | Coverage 0.934 too low. | e10a87e7da68a1417f1b7b94102987fe | 694 | Pfam | PF12925 | E2 domain of amyloid precursor protein | 278 | 466 | 5.8E-78 | T | 22-09-2020 | IPR024329 | Amyloidogenic glycoprotein, E2 domain |
| UnnamedSample_HQ_transcript/49576|m.13927 | UnnamedSample_HQ_transcript/49576 | Coverage 0.934 too low. | e10a87e7da68a1417f1b7b94102987fe | 694 | Pfam | PF12924 | Copper-binding of amyloid precursor, CuBD | 148 | 204 | 4.5E-23 | T | 22-09-2020 | IPR011178 | Amyloidogenic glycoprotein, copper-binding |
| UnnamedSample_HQ_transcript/49576|m.13927 | UnnamedSample_HQ_transcript/49576 | Coverage 0.934 too low. | e10a87e7da68a1417f1b7b94102987fe | 694 | Pfam | PF02177 | Amyloid A4 N-terminal heparin-binding | 38 | 147 | 5.3E-37 | T | 22-09-2020 | IPR015849 | Amyloidogenic glycoprotein, heparin-binding |
| UnnamedSample_HQ_transcript/49576|m.13927 | UnnamedSample_HQ_transcript/49576 | Coverage 0.934 too low. | e10a87e7da68a1417f1b7b94102987fe | 694 | Pfam | PF10515 | Beta-amyloid precursor protein C-terminus | 643 | 693 | 7.8E-27 | T | 22-09-2020 | IPR019543 | Beta-amyloid precursor protein C-terminal |
| UnnamedSample_HQ_transcript/44423|m.12802 | UnnamedSample_HQ_transcript/44423 | Coverage 0.867 too low. | e10a87e7da68a1417f1b7b94102987fe | 694 | Pfam | PF12925 | E2 domain of amyloid precursor protein | 278 | 466 | 5.8E-78 | T | 22-09-2020 | IPR024329 | Amyloidogenic glycoprotein, E2 domain |
| UnnamedSample_HQ_transcript/44423|m.12802 | UnnamedSample_HQ_transcript/44423 | Coverage 0.867 too low. | e10a87e7da68a1417f1b7b94102987fe | 694 | Pfam | PF12924 | Copper-binding of amyloid precursor, CuBD | 148 | 204 | 4.5E-23 | T | 22-09-2020 | IPR011178 | Amyloidogenic glycoprotein, copper-binding |
| UnnamedSample_HQ_transcript/44423|m.12802 | UnnamedSample_HQ_transcript/44423 | Coverage 0.867 too low. | e10a87e7da68a1417f1b7b94102987fe | 694 | Pfam | PF02177 | Amyloid A4 N-terminal heparin-binding | 38 | 147 | 5.3E-37 | T | 22-09-2020 | IPR015849 | Amyloidogenic glycoprotein, heparin-binding |
| UnnamedSample_HQ_transcript/44423|m.12802 | UnnamedSample_HQ_transcript/44423 | Coverage 0.867 too low. | e10a87e7da68a1417f1b7b94102987fe | 694 | Pfam | PF10515 | Beta-amyloid precursor protein C-terminus | 643 | 693 | 7.8E-27 | T | 22-09-2020 | IPR019543 | Beta-amyloid precursor protein C-terminal |
| UnnamedSample_HQ_transcript/1838|m.996 | UnnamedSample_HQ_transcript/1838 | Coverage 0.752 too low. | ec4e47d4f0d1b817d0644f7c7a727714 | 1329 | Pfam | PF00078 | Reverse transcriptase (RNA-dependent DNA polymerase) | 564 | 689 | 7.2E-13 | T | 22-09-2020 | IPR000477 | Reverse transcriptase domain |
| UnnamedSample_HQ_transcript/1838|m.996 | UnnamedSample_HQ_transcript/1838 | Coverage 0.752 too low. | ec4e47d4f0d1b817d0644f7c7a727714 | 1329 | Pfam | PF17919 | RNase H-like domain found in reverse transcriptase | 753 | 850 | 2.9E-35 | T | 22-09-2020 | IPR041577 | Reverse transcriptase/retrotransposon-derived protein, RNase H-like domain |
| UnnamedSample_HQ_transcript/1838|m.996 | UnnamedSample_HQ_transcript/1838 | Coverage 0.752 too low. | ec4e47d4f0d1b817d0644f7c7a727714 | 1329 | Pfam | PF00665 | Integrase core domain | 1055 | 1145 | 3.1E-11 | T | 22-09-2020 | IPR001584 | Integrase, catalytic core |
| UnnamedSample_HQ_transcript/1838|m.996 | UnnamedSample_HQ_transcript/1838 | Coverage 0.752 too low. | ec4e47d4f0d1b817d0644f7c7a727714 | 1329 | Pfam | PF17921 | Integrase zinc binding domain | 986 | 1039 | 8.1E-17 | T | 22-09-2020 | IPR041588 | Integrase zinc-binding domain |
| UnnamedSample_HQ_transcript/7171|m.2916 | UnnamedSample_HQ_transcript/7171 | Unmapped. | 1608acb3eab2f335de829f3227acf1b8 | 1386 | Pfam | PF17222 | Viral cysteine endopeptidase C107 | 195 | 450 | 7.4E-11 | T | 22-09-2020 | IPR033777 | Viral cysteine endopeptidase C107 |
| UnnamedSample_HQ_transcript/15921|m.5683 | UnnamedSample_HQ_transcript/15921 | Coverage 0.912 too low. | 6f3a2a4d1ea69d2b8242458e215f5064 | 1139 | Pfam | PF12947 | EGF domain | 1031 | 1067 | 5.9E-7 | T | 22-09-2020 | IPR024731 | EGF domain |
| UnnamedSample_HQ_transcript/15921|m.5683 | UnnamedSample_HQ_transcript/15921 | Coverage 0.912 too low. | 6f3a2a4d1ea69d2b8242458e215f5064 | 1139 | Pfam | PF12947 | EGF domain | 824 | 861 | 7.4E-7 | T | 22-09-2020 | IPR024731 | EGF domain |
| UnnamedSample_HQ_transcript/15921|m.5683 | UnnamedSample_HQ_transcript/15921 | Coverage 0.912 too low. | 6f3a2a4d1ea69d2b8242458e215f5064 | 1139 | Pfam | PF07645 | Calcium-binding EGF domain | 601 | 636 | 4.4E-11 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/15921|m.5683 | UnnamedSample_HQ_transcript/15921 | Coverage 0.912 too low. | 6f3a2a4d1ea69d2b8242458e215f5064 | 1139 | Pfam | PF07645 | Calcium-binding EGF domain | 694 | 735 | 1.1E-6 | T | 22-09-2020 | IPR001881 | EGF-like calcium-binding domain |
| UnnamedSample_HQ_transcript/15921|m.5683 | UnnamedSample_HQ_transcript/15921 | Coverage 0.912 too low. | 6f3a2a4d1ea69d2b8242458e215f5064 | 1139 | Pfam | PF07474 | G2F domain | 318 | 499 | 6.4E-52 | T | 22-09-2020 | IPR006605 | G2 nidogen/fibulin G2F |
| UnnamedSample_HQ_transcript/15921|m.5683 | UnnamedSample_HQ_transcript/15921 | Coverage 0.912 too low. | 6f3a2a4d1ea69d2b8242458e215f5064 | 1139 | Pfam | PF12661 | Human growth factor-like EGF | 660 | 678 | 0.035 | T | 22-09-2020 | IPR013032 | EGF-like, conserved site |
| UnnamedSample_HQ_transcript/15921|m.5683 | UnnamedSample_HQ_transcript/15921 | Coverage 0.912 too low. | 6f3a2a4d1ea69d2b8242458e215f5064 | 1139 | Pfam | PF06119 | Nidogen-like | 165 | 249 | 2.7E-19 | T | 22-09-2020 | IPR003886 | NIDO domain |
| UnnamedSample_HQ_transcript/35991|m.10931 | UnnamedSample_HQ_transcript/35991 | Coverage 0.983 too low. | 5d7a95bfd7bc94bdc35cb91e1ddc8846 | 753 | Pfam | PF00806 | Pumilio-family RNA binding repeat | 530 | 563 | 4.6E-11 | T | 22-09-2020 | IPR001313 | Pumilio RNA-binding repeat |
| UnnamedSample_HQ_transcript/35991|m.10931 | UnnamedSample_HQ_transcript/35991 | Coverage 0.983 too low. | 5d7a95bfd7bc94bdc35cb91e1ddc8846 | 753 | Pfam | PF00806 | Pumilio-family RNA binding repeat | 675 | 708 | 5.1E-7 | T | 22-09-2020 | IPR001313 | Pumilio RNA-binding repeat |
| UnnamedSample_HQ_transcript/35991|m.10931 | UnnamedSample_HQ_transcript/35991 | Coverage 0.983 too low. | 5d7a95bfd7bc94bdc35cb91e1ddc8846 | 753 | Pfam | PF00806 | Pumilio-family RNA binding repeat | 641 | 671 | 3.7E-8 | T | 22-09-2020 | IPR001313 | Pumilio RNA-binding repeat |
| UnnamedSample_HQ_transcript/35991|m.10931 | UnnamedSample_HQ_transcript/35991 | Coverage 0.983 too low. | 5d7a95bfd7bc94bdc35cb91e1ddc8846 | 753 | Pfam | PF00806 | Pumilio-family RNA binding repeat | 458 | 491 | 1.2E-10 | T | 22-09-2020 | IPR001313 | Pumilio RNA-binding repeat |
| UnnamedSample_HQ_transcript/35991|m.10931 | UnnamedSample_HQ_transcript/35991 | Coverage 0.983 too low. | 5d7a95bfd7bc94bdc35cb91e1ddc8846 | 753 | Pfam | PF00806 | Pumilio-family RNA binding repeat | 496 | 525 | 3.1E-8 | T | 22-09-2020 | IPR001313 | Pumilio RNA-binding repeat |
| UnnamedSample_HQ_transcript/35991|m.10931 | UnnamedSample_HQ_transcript/35991 | Coverage 0.983 too low. | 5d7a95bfd7bc94bdc35cb91e1ddc8846 | 753 | Pfam | PF00806 | Pumilio-family RNA binding repeat | 566 | 597 | 2.8E-6 | T | 22-09-2020 | IPR001313 | Pumilio RNA-binding repeat |
| UnnamedSample_HQ_transcript/35991|m.10931 | UnnamedSample_HQ_transcript/35991 | Coverage 0.983 too low. | 5d7a95bfd7bc94bdc35cb91e1ddc8846 | 753 | Pfam | PF00806 | Pumilio-family RNA binding repeat | 718 | 747 | 8.5E-8 | T | 22-09-2020 | IPR001313 | Pumilio RNA-binding repeat |
| UnnamedSample_HQ_transcript/35991|m.10931 | UnnamedSample_HQ_transcript/35991 | Coverage 0.983 too low. | 5d7a95bfd7bc94bdc35cb91e1ddc8846 | 753 | Pfam | PF00806 | Pumilio-family RNA binding repeat | 602 | 636 | 4.3E-15 | T | 22-09-2020 | IPR001313 | Pumilio RNA-binding repeat |
| UnnamedSample_HQ_transcript/37354|m.11243 | UnnamedSample_HQ_transcript/37354 | Coverage 0.918 too low. | 1df4a4a1d25ba941dc27e8098711088c | 663 | Pfam | PF00149 | Calcineurin-like phosphoesterase | 261 | 524 | 1.9E-24 | T | 22-09-2020 | IPR004843 | Calcineurin-like phosphoesterase domain, ApaH type |
| UnnamedSample_HQ_transcript/34318|m.10554 | UnnamedSample_HQ_transcript/34318 | Coverage 0.910 too low. | 17ec93ed92688e705f40e2ad0da44d89 | 556 | Pfam | PF00400 | WD domain, G-beta repeat | 394 | 430 | 0.0049 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/34318|m.10554 | UnnamedSample_HQ_transcript/34318 | Coverage 0.910 too low. | 17ec93ed92688e705f40e2ad0da44d89 | 556 | Pfam | PF00400 | WD domain, G-beta repeat | 266 | 297 | 0.069 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/34318|m.10554 | UnnamedSample_HQ_transcript/34318 | Coverage 0.910 too low. | 17ec93ed92688e705f40e2ad0da44d89 | 556 | Pfam | PF00400 | WD domain, G-beta repeat | 364 | 388 | 0.11 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/200|m.179 | UnnamedSample_HQ_transcript/200 | Unmapped. | befc18485215efc659fb83942f8af320 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/339|m.264 | UnnamedSample_HQ_transcript/339 | Unmapped. | befc18485215efc659fb83942f8af320 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/199|m.178 | UnnamedSample_HQ_transcript/199 | Unmapped. | befc18485215efc659fb83942f8af320 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/202|m.180 | UnnamedSample_HQ_transcript/202 | Unmapped. | befc18485215efc659fb83942f8af320 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/334|m.262 | UnnamedSample_HQ_transcript/334 | Unmapped. | befc18485215efc659fb83942f8af320 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/383|m.296 | UnnamedSample_HQ_transcript/383 | Unmapped. | befc18485215efc659fb83942f8af320 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/210|m.187 | UnnamedSample_HQ_transcript/210 | Unmapped. | befc18485215efc659fb83942f8af320 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/219|m.193 | UnnamedSample_HQ_transcript/219 | Unmapped. | befc18485215efc659fb83942f8af320 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/403|m.313 | UnnamedSample_HQ_transcript/403 | Unmapped. | befc18485215efc659fb83942f8af320 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/267|m.223 | UnnamedSample_HQ_transcript/267 | Unmapped. | befc18485215efc659fb83942f8af320 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/224|m.197 | UnnamedSample_HQ_transcript/224 | Unmapped. | befc18485215efc659fb83942f8af320 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/247|m.211 | UnnamedSample_HQ_transcript/247 | Unmapped. | befc18485215efc659fb83942f8af320 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/10781|m.4075 | UnnamedSample_HQ_transcript/10781 | Unmapped. | befc18485215efc659fb83942f8af320 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/367|m.287 | UnnamedSample_HQ_transcript/367 | Unmapped. | befc18485215efc659fb83942f8af320 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/239|m.205 | UnnamedSample_HQ_transcript/239 | Unmapped. | befc18485215efc659fb83942f8af320 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/233|m.201 | UnnamedSample_HQ_transcript/233 | Unmapped. | befc18485215efc659fb83942f8af320 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/301|m.246 | UnnamedSample_HQ_transcript/301 | Unmapped. | befc18485215efc659fb83942f8af320 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/358|m.279 | UnnamedSample_HQ_transcript/358 | Unmapped. | befc18485215efc659fb83942f8af320 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/311|m.250 | UnnamedSample_HQ_transcript/311 | Unmapped. | befc18485215efc659fb83942f8af320 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/206|m.183 | UnnamedSample_HQ_transcript/206 | Unmapped. | befc18485215efc659fb83942f8af320 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/209|m.186 | UnnamedSample_HQ_transcript/209 | Unmapped. | befc18485215efc659fb83942f8af320 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/242|m.207 | UnnamedSample_HQ_transcript/242 | Unmapped. | befc18485215efc659fb83942f8af320 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/223|m.196 | UnnamedSample_HQ_transcript/223 | Unmapped. | befc18485215efc659fb83942f8af320 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/396|m.306 | UnnamedSample_HQ_transcript/396 | Unmapped. | befc18485215efc659fb83942f8af320 | 1181 | Pfam | PF13087 | AAA domain | 12 | 183 | 8.8E-24 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/84|m.83 | UnnamedSample_HQ_transcript/84 | Unmapped. | d3755f379dfe6ee2a3cf7047a8a7aca3 | 1604 | Pfam | PF13086 | AAA domain | 252 | 322 | 7.8E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/84|m.83 | UnnamedSample_HQ_transcript/84 | Unmapped. | d3755f379dfe6ee2a3cf7047a8a7aca3 | 1604 | Pfam | PF13087 | AAA domain | 435 | 606 | 1.4E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/136|m.134 | UnnamedSample_HQ_transcript/136 | Unmapped. | d3755f379dfe6ee2a3cf7047a8a7aca3 | 1604 | Pfam | PF13086 | AAA domain | 252 | 322 | 7.8E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/136|m.134 | UnnamedSample_HQ_transcript/136 | Unmapped. | d3755f379dfe6ee2a3cf7047a8a7aca3 | 1604 | Pfam | PF13087 | AAA domain | 435 | 606 | 1.4E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/86|m.85 | UnnamedSample_HQ_transcript/86 | Unmapped. | d3755f379dfe6ee2a3cf7047a8a7aca3 | 1604 | Pfam | PF13086 | AAA domain | 252 | 322 | 7.8E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/86|m.85 | UnnamedSample_HQ_transcript/86 | Unmapped. | d3755f379dfe6ee2a3cf7047a8a7aca3 | 1604 | Pfam | PF13087 | AAA domain | 435 | 606 | 1.4E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/6|m.7 | UnnamedSample_HQ_transcript/6 | Unmapped. | d3755f379dfe6ee2a3cf7047a8a7aca3 | 1604 | Pfam | PF13086 | AAA domain | 252 | 322 | 7.8E-9 | T | 22-09-2020 | IPR041677 | DNA2/NAM7 helicase, helicase domain |
| UnnamedSample_HQ_transcript/6|m.7 | UnnamedSample_HQ_transcript/6 | Unmapped. | d3755f379dfe6ee2a3cf7047a8a7aca3 | 1604 | Pfam | PF13087 | AAA domain | 435 | 606 | 1.4E-23 | T | 22-09-2020 | IPR041679 | DNA2/NAM7 helicase-like, C-terminal |
| UnnamedSample_HQ_transcript/83441|m.20256 | UnnamedSample_HQ_transcript/83441 | Coverage 0.984 too low. | 12ccb88fe50bf0d260bdd2be8d55bfa2 | 334 | Pfam | PF00134 | Cyclin, N-terminal domain | 89 | 208 | 5.8E-7 | T | 22-09-2020 | IPR006671 | Cyclin, N-terminal |
| UnnamedSample_HQ_transcript/16909|m.5975 | UnnamedSample_HQ_transcript/16909 | Coverage 0.227 too low. | 249a81aad9d87f3bd1048f54d60b1d34 | 426 | Pfam | PF00105 | Zinc finger, C4 type (two domains) | 110 | 178 | 1.1E-31 | T | 22-09-2020 | IPR001628 | Zinc finger, nuclear hormone receptor-type |
| UnnamedSample_HQ_transcript/16909|m.5975 | UnnamedSample_HQ_transcript/16909 | Coverage 0.227 too low. | 249a81aad9d87f3bd1048f54d60b1d34 | 426 | Pfam | PF00104 | Ligand-binding domain of nuclear hormone receptor | 232 | 407 | 7.1E-38 | T | 22-09-2020 | IPR000536 | Nuclear hormone receptor, ligand-binding domain |
| UnnamedSample_HQ_transcript/49093|m.13828 | UnnamedSample_HQ_transcript/49093 | Coverage 0.898 too low. | 83803da5a09a8ec1abb380b837b80140 | 380 | Pfam | PF19056 | WD40 repeated domain | 40 | 268 | 8.3E-62 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/65988|m.17206 | UnnamedSample_HQ_transcript/65988 | Coverage 0.983 too low. | b5fabd25de1737e53e8f40c01d220d00 | 458 | Pfam | PF01230 | HIT domain | 323 | 416 | 5.4E-22 | T | 22-09-2020 | IPR001310 | Histidine triad (HIT) protein |
| UnnamedSample_HQ_transcript/65988|m.17206 | UnnamedSample_HQ_transcript/65988 | Coverage 0.983 too low. | b5fabd25de1737e53e8f40c01d220d00 | 458 | Pfam | PF00795 | Carbon-nitrogen hydrolase | 35 | 286 | 7.1E-63 | T | 22-09-2020 | IPR003010 | Carbon-nitrogen hydrolase |
| UnnamedSample_HQ_transcript/79599|m.19642 | UnnamedSample_HQ_transcript/79599 | Coverage 0.978 too low. | b5fabd25de1737e53e8f40c01d220d00 | 458 | Pfam | PF01230 | HIT domain | 323 | 416 | 5.4E-22 | T | 22-09-2020 | IPR001310 | Histidine triad (HIT) protein |
| UnnamedSample_HQ_transcript/79599|m.19642 | UnnamedSample_HQ_transcript/79599 | Coverage 0.978 too low. | b5fabd25de1737e53e8f40c01d220d00 | 458 | Pfam | PF00795 | Carbon-nitrogen hydrolase | 35 | 286 | 7.1E-63 | T | 22-09-2020 | IPR003010 | Carbon-nitrogen hydrolase |
| UnnamedSample_HQ_transcript/108494|m.23645 | UnnamedSample_HQ_transcript/108494 | Coverage 0.233 too low. | 393de8e402f068914cdd168322c30cf8 | 239 | Pfam | PF01553 | Acyltransferase | 14 | 133 | 1.2E-14 | T | 22-09-2020 | IPR002123 | Phospholipid/glycerol acyltransferase |
| UnnamedSample_HQ_transcript/60836|m.16226 | UnnamedSample_HQ_transcript/60836 | Coverage 0.908 too low. | 6063a6e2c7ed71d73cf014184ecfe8bf | 436 | Pfam | PF02436 | Conserved carboxylase domain | 119 | 317 | 1.0E-70 | T | 22-09-2020 | IPR003379 | Carboxylase, conserved domain |
| UnnamedSample_HQ_transcript/60836|m.16226 | UnnamedSample_HQ_transcript/60836 | Coverage 0.908 too low. | 6063a6e2c7ed71d73cf014184ecfe8bf | 436 | Pfam | PF00364 | Biotin-requiring enzyme | 368 | 435 | 5.6E-19 | T | 22-09-2020 | IPR000089 | Biotin/lipoyl attachment |
| UnnamedSample_HQ_transcript/60836|m.16226 | UnnamedSample_HQ_transcript/60836 | Coverage 0.908 too low. | 6063a6e2c7ed71d73cf014184ecfe8bf | 436 | Pfam | PF00682 | HMGL-like | 1 | 93 | 3.4E-15 | T | 22-09-2020 | IPR000891 | Pyruvate carboxyltransferase |
| UnnamedSample_HQ_transcript/13016|m.4822 | UnnamedSample_HQ_transcript/13016 | Coverage 0.833 too low. | 444619136b79734e75a28aa85ae80413 | 1030 | Pfam | PF00595 | PDZ domain | 9 | 84 | 3.7E-5 | T | 22-09-2020 | IPR001478 | PDZ domain |
| UnnamedSample_HQ_transcript/40843|m.12033 | UnnamedSample_HQ_transcript/40843 | Identity 0.914 too low. | 43c350e8cca13f1ad2e82065a2a336ab | 439 | Pfam | PF08953 | Domain of unknown function (DUF1899) | 10 | 74 | 1.1E-31 | T | 22-09-2020 | IPR015048 | Domain of unknown function DUF1899 |
| UnnamedSample_HQ_transcript/40843|m.12033 | UnnamedSample_HQ_transcript/40843 | Identity 0.914 too low. | 43c350e8cca13f1ad2e82065a2a336ab | 439 | Pfam | PF00400 | WD domain, G-beta repeat | 81 | 114 | 5.7E-6 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/40843|m.12033 | UnnamedSample_HQ_transcript/40843 | Identity 0.914 too low. | 43c350e8cca13f1ad2e82065a2a336ab | 439 | Pfam | PF00400 | WD domain, G-beta repeat | 171 | 207 | 0.0055 | T | 22-09-2020 | IPR001680 | WD40 repeat |
| UnnamedSample_HQ_transcript/40843|m.12033 | UnnamedSample_HQ_transcript/40843 | Identity 0.914 too low. | 43c350e8cca13f1ad2e82065a2a336ab | 439 | Pfam | PF16300 | Type of WD40 repeat | 349 | 391 | 3.1E-21 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/108280|m.23612 | UnnamedSample_HQ_transcript/108280 | Coverage 0.988 too low. | 2f2a4feb9a7eb37bbdfe99c2c9e5e0c9 | 247 | Pfam | PF01564 | Spermine/spermidine synthase domain | 24 | 207 | 4.1E-64 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/76856|m.19181 | UnnamedSample_HQ_transcript/76856 | Coverage 0.081 too low. | 245d24d52ddbb8407cc1c90e8d5fc111 | 438 | Pfam | PF00063 | Myosin head (motor domain) | 1 | 340 | 7.9E-109 | T | 22-09-2020 | IPR001609 | Myosin head, motor domain |
| UnnamedSample_HQ_transcript/76856|m.19181 | UnnamedSample_HQ_transcript/76856 | Coverage 0.081 too low. | 245d24d52ddbb8407cc1c90e8d5fc111 | 438 | Pfam | PF00612 | IQ calmodulin-binding motif | 379 | 398 | 0.0024 | T | 22-09-2020 | IPR000048 | IQ motif, EF-hand binding site |
| UnnamedSample_HQ_transcript/76856|m.19181 | UnnamedSample_HQ_transcript/76856 | Coverage 0.081 too low. | 245d24d52ddbb8407cc1c90e8d5fc111 | 438 | Pfam | PF00612 | IQ calmodulin-binding motif | 402 | 418 | 0.0034 | T | 22-09-2020 | IPR000048 | IQ motif, EF-hand binding site |
| UnnamedSample_HQ_transcript/76856|m.19181 | UnnamedSample_HQ_transcript/76856 | Coverage 0.081 too low. | 245d24d52ddbb8407cc1c90e8d5fc111 | 438 | Pfam | PF00612 | IQ calmodulin-binding motif | 360 | 375 | 0.0099 | T | 22-09-2020 | IPR000048 | IQ motif, EF-hand binding site |
| UnnamedSample_HQ_transcript/24915|m.8199 | UnnamedSample_HQ_transcript/24915 | Coverage 0.718 too low. | fc34f8effacb1241a185261aee3bcd5e | 879 | Pfam | PF03131 | bZIP Maf transcription factor | 756 | 844 | 1.5E-21 | T | 22-09-2020 | IPR004826 | Basic leucine zipper domain, Maf-type |
| UnnamedSample_HQ_transcript/58518|m.15751 | UnnamedSample_HQ_transcript/58518 | Unmapped. | 25706fae423ab9dad3e9c4f476c25c73 | 540 | Pfam | PF00910 | RNA helicase | 55 | 163 | 1.2E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/66515|m.17317 | UnnamedSample_HQ_transcript/66515 | Unmapped. | 25706fae423ab9dad3e9c4f476c25c73 | 540 | Pfam | PF00910 | RNA helicase | 55 | 163 | 1.2E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/71992|m.18300 | UnnamedSample_HQ_transcript/71992 | Unmapped. | 25706fae423ab9dad3e9c4f476c25c73 | 540 | Pfam | PF00910 | RNA helicase | 55 | 163 | 1.2E-18 | T | 22-09-2020 | IPR000605 | Helicase, superfamily 3, single-stranded DNA/RNA virus |
| UnnamedSample_HQ_transcript/120596|m.24889 | UnnamedSample_HQ_transcript/120596 | Coverage 0.983 too low. | 8ef6aa45595c9a795cd75697f65ca5dc | 160 | Pfam | PF13855 | Leucine rich repeat | 57 | 114 | 2.6E-13 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/111339|m.24004 | UnnamedSample_HQ_transcript/111339 | Coverage 0.905 too low. | 8ef6aa45595c9a795cd75697f65ca5dc | 160 | Pfam | PF13855 | Leucine rich repeat | 57 | 114 | 2.6E-13 | T | 22-09-2020 | IPR001611 | Leucine-rich repeat |
| UnnamedSample_HQ_transcript/60931|m.16246 | UnnamedSample_HQ_transcript/60931 | Identity 0.579 too low. | 598fd6b4ca249fdfe4536d0af2d64b64 | 434 | Pfam | PF02225 | PA domain | 65 | 154 | 1.6E-7 | T | 22-09-2020 | IPR003137 | PA domain |
| UnnamedSample_HQ_transcript/60931|m.16246 | UnnamedSample_HQ_transcript/60931 | Identity 0.579 too low. | 598fd6b4ca249fdfe4536d0af2d64b64 | 434 | Pfam | PF13639 | Ring finger domain | 242 | 285 | 2.8E-13 | T | 22-09-2020 | IPR001841 | Zinc finger, RING-type |
| UnnamedSample_HQ_transcript/54646|m.14977 | UnnamedSample_HQ_transcript/54646 | Coverage 0.133 too low. | 87e11d9509465c584ab962255faf89b9 | 548 | Pfam | PF00372 | Hemocyanin, copper containing domain | 6 | 267 | 2.1E-55 | T | 22-09-2020 | IPR000896 | Hemocyanin/hexamerin middle domain |
| UnnamedSample_HQ_transcript/54646|m.14977 | UnnamedSample_HQ_transcript/54646 | Coverage 0.133 too low. | 87e11d9509465c584ab962255faf89b9 | 548 | Pfam | PF03723 | Hemocyanin, ig-like domain | 277 | 540 | 3.5E-63 | T | 22-09-2020 | IPR005203 | Hemocyanin, C-terminal |
| UnnamedSample_HQ_transcript/91745|m.21506 | UnnamedSample_HQ_transcript/91745 | Coverage 0.835 too low. | dedfdf66bdde0e03043fbae60e4aa434 | 232 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 26 | 88 | 1.2E-15 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/91745|m.21506 | UnnamedSample_HQ_transcript/91745 | Coverage 0.835 too low. | dedfdf66bdde0e03043fbae60e4aa434 | 232 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 105 | 160 | 1.3E-9 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/91745|m.21506 | UnnamedSample_HQ_transcript/91745 | Coverage 0.835 too low. | dedfdf66bdde0e03043fbae60e4aa434 | 232 | Pfam | PF00098 | Zinc knuckle | 186 | 202 | 4.7E-7 | T | 22-09-2020 | IPR001878 | Zinc finger, CCHC-type |
| UnnamedSample_HQ_transcript/94785|m.21922 | UnnamedSample_HQ_transcript/94785 | Coverage 0.413 too low. | 3c978730351ec175b37c5c64ae60f142 | 364 | Pfam | PF13176 | Tetratricopeptide repeat | 195 | 223 | 1.6E-4 | T | 22-09-2020 | IPR019734 | Tetratricopeptide repeat |
| UnnamedSample_HQ_transcript/94785|m.21922 | UnnamedSample_HQ_transcript/94785 | Coverage 0.413 too low. | 3c978730351ec175b37c5c64ae60f142 | 364 | Pfam | PF13424 | Tetratricopeptide repeat | 106 | 180 | 2.8E-21 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/94785|m.21922 | UnnamedSample_HQ_transcript/94785 | Coverage 0.413 too low. | 3c978730351ec175b37c5c64ae60f142 | 364 | Pfam | PF13424 | Tetratricopeptide repeat | 23 | 97 | 1.1E-17 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/94785|m.21922 | UnnamedSample_HQ_transcript/94785 | Coverage 0.413 too low. | 3c978730351ec175b37c5c64ae60f142 | 364 | Pfam | PF13374 | Tetratricopeptide repeat | 275 | 308 | 6.8E-5 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/6935|m.2840 | UnnamedSample_HQ_transcript/6935 | Identity 0.899 too low. | 62ddfb3dc6451a3d7006abe9d5df4925 | 814 | Pfam | PF00567 | Tudor domain | 374 | 498 | 2.2E-17 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/6935|m.2840 | UnnamedSample_HQ_transcript/6935 | Identity 0.899 too low. | 62ddfb3dc6451a3d7006abe9d5df4925 | 814 | Pfam | PF00567 | Tudor domain | 627 | 692 | 3.0E-11 | T | 22-09-2020 | IPR002999 | Tudor domain |
| UnnamedSample_HQ_transcript/63101|m.16653 | UnnamedSample_HQ_transcript/63101 | Coverage 0.950 too low. | d6270d6eb8f653d2e7352c72e8f75fd7 | 362 | Pfam | PF01576 | Myosin tail | 2 | 361 | 5.9E-55 | T | 22-09-2020 | IPR002928 | Myosin tail |
| UnnamedSample_HQ_transcript/55560|m.15147 | UnnamedSample_HQ_transcript/55560 | Unmapped. | 44ccb36be4c7313f4c7a4016685a664f | 558 | Pfam | PF11875 | Domain of unknown function (DUF3395) | 406 | 549 | 8.4E-47 | T | 22-09-2020 | IPR024586 | DnaJ-like protein C11, C-terminal |
| UnnamedSample_HQ_transcript/55560|m.15147 | UnnamedSample_HQ_transcript/55560 | Unmapped. | 44ccb36be4c7313f4c7a4016685a664f | 558 | Pfam | PF00226 | DnaJ domain | 13 | 78 | 1.3E-20 | T | 22-09-2020 | IPR001623 | DnaJ domain |
| UnnamedSample_HQ_transcript/58195|m.15694 | UnnamedSample_HQ_transcript/58195 | Unmapped. | 44ccb36be4c7313f4c7a4016685a664f | 558 | Pfam | PF11875 | Domain of unknown function (DUF3395) | 406 | 549 | 8.4E-47 | T | 22-09-2020 | IPR024586 | DnaJ-like protein C11, C-terminal |
| UnnamedSample_HQ_transcript/58195|m.15694 | UnnamedSample_HQ_transcript/58195 | Unmapped. | 44ccb36be4c7313f4c7a4016685a664f | 558 | Pfam | PF00226 | DnaJ domain | 13 | 78 | 1.3E-20 | T | 22-09-2020 | IPR001623 | DnaJ domain |
| UnnamedSample_HQ_transcript/34663|m.10642 | UnnamedSample_HQ_transcript/34663 | Coverage 0.378 too low. | 92fb489aab978c60b0b670e8655ce5cd | 846 | Pfam | PF00439 | Bromodomain | 222 | 302 | 3.2E-15 | T | 22-09-2020 | IPR001487 | Bromodomain |
| UnnamedSample_HQ_transcript/15649|m.5600 | UnnamedSample_HQ_transcript/15649 | Coverage 0.940 too low. | bb46380c59eabf8d9a0e0fc55bf6d28a | 568 | Pfam | PF01608 | I/LWEQ domain | 412 | 560 | 2.8E-55 | T | 22-09-2020 | IPR002558 | I/LWEQ domain |
| UnnamedSample_HQ_transcript/17675|m.6214 | UnnamedSample_HQ_transcript/17675 | Coverage 0.795 too low. | cc235aa277981990e8ed2db447085654 | 124 | Pfam | PF00001 | 7 transmembrane receptor (rhodopsin family) | 1 | 57 | 1.1E-11 | T | 22-09-2020 | IPR017452 | GPCR, rhodopsin-like, 7TM |
| UnnamedSample_HQ_transcript/27983|m.8964 | UnnamedSample_HQ_transcript/27983 | Coverage 0.964 too low. | 1154f39bf95e6d1bd7ff20e94d25ea1f | 747 | Pfam | PF09380 | FERM C-terminal PH-like domain | 230 | 318 | 1.0E-22 | T | 22-09-2020 | IPR018980 | FERM, C-terminal PH-like domain |
| UnnamedSample_HQ_transcript/27983|m.8964 | UnnamedSample_HQ_transcript/27983 | Coverage 0.964 too low. | 1154f39bf95e6d1bd7ff20e94d25ea1f | 747 | Pfam | PF08736 | FERM adjacent (FA) | 327 | 368 | 1.6E-13 | T | 22-09-2020 | IPR014847 | FERM adjacent (FA) |
| UnnamedSample_HQ_transcript/27983|m.8964 | UnnamedSample_HQ_transcript/27983 | Coverage 0.964 too low. | 1154f39bf95e6d1bd7ff20e94d25ea1f | 747 | Pfam | PF09379 | FERM N-terminal domain | 38 | 100 | 5.3E-18 | T | 22-09-2020 | IPR018979 | FERM, N-terminal |
| UnnamedSample_HQ_transcript/27983|m.8964 | UnnamedSample_HQ_transcript/27983 | Coverage 0.964 too low. | 1154f39bf95e6d1bd7ff20e94d25ea1f | 747 | Pfam | PF00373 | FERM central domain | 118 | 223 | 1.5E-22 | T | 22-09-2020 | IPR019748 | FERM central domain |
| UnnamedSample_HQ_transcript/99240|m.22528 | UnnamedSample_HQ_transcript/99240 | Coverage 0.985 too low. | d8a53199e6433548e31799af0e206996 | 155 | Pfam | PF00044 | Glyceraldehyde 3-phosphate dehydrogenase, NAD binding domain | 1 | 62 | 6.3E-19 | T | 22-09-2020 | IPR020828 | Glyceraldehyde 3-phosphate dehydrogenase, NAD(P) binding domain |
| UnnamedSample_HQ_transcript/99240|m.22528 | UnnamedSample_HQ_transcript/99240 | Coverage 0.985 too low. | d8a53199e6433548e31799af0e206996 | 155 | Pfam | PF02800 | Glyceraldehyde 3-phosphate dehydrogenase, C-terminal domain | 115 | 144 | 4.2E-10 | T | 22-09-2020 | IPR020829 | Glyceraldehyde 3-phosphate dehydrogenase, catalytic domain |
| UnnamedSample_HQ_transcript/46969|m.13355 | UnnamedSample_HQ_transcript/46969 | Coverage 0.871 too low. | 369d4b24399ebd4386795513c844da34 | 455 | Pfam | PF12872 | OST-HTH/LOTUS domain | 7 | 61 | 5.4E-8 | T | 22-09-2020 | IPR025605 | OST-HTH/LOTUS domain |
| UnnamedSample_HQ_transcript/3082|m.1473 | UnnamedSample_HQ_transcript/3082 | Identity 0.805 too low. | 16fec35714d1ab304e2cde329d1eff4f | 399 | Pfam | PF06218 | Nitrogen permease regulator 2 | 290 | 390 | 2.0E-12 | T | 22-09-2020 | IPR009348 | Nitrogen permease regulator 2 |
| UnnamedSample_HQ_transcript/3082|m.1473 | UnnamedSample_HQ_transcript/3082 | Identity 0.805 too low. | 16fec35714d1ab304e2cde329d1eff4f | 399 | Pfam | PF06218 | Nitrogen permease regulator 2 | 16 | 286 | 8.0E-64 | T | 22-09-2020 | IPR009348 | Nitrogen permease regulator 2 |
| UnnamedSample_HQ_transcript/89694|m.21191 | UnnamedSample_HQ_transcript/89694 | Coverage 0.881 too low. | fe2b87ccfdf26e7fd0b9a65207c514e2 | 391 | Pfam | PF08880 | QLQ | 87 | 121 | 2.5E-10 | T | 22-09-2020 | IPR014978 | Glutamine-Leucine-Glutamine, QLQ |
| UnnamedSample_HQ_transcript/89694|m.21191 | UnnamedSample_HQ_transcript/89694 | Coverage 0.881 too low. | fe2b87ccfdf26e7fd0b9a65207c514e2 | 391 | Pfam | PF07529 | HSA | 339 | 391 | 4.0E-12 | T | 22-09-2020 | IPR014012 | Helicase/SANT-associated domain |
| UnnamedSample_HQ_transcript/75555|m.18949 | UnnamedSample_HQ_transcript/75555 | Unmapped. | fe2b87ccfdf26e7fd0b9a65207c514e2 | 391 | Pfam | PF08880 | QLQ | 87 | 121 | 2.5E-10 | T | 22-09-2020 | IPR014978 | Glutamine-Leucine-Glutamine, QLQ |
| UnnamedSample_HQ_transcript/75555|m.18949 | UnnamedSample_HQ_transcript/75555 | Unmapped. | fe2b87ccfdf26e7fd0b9a65207c514e2 | 391 | Pfam | PF07529 | HSA | 339 | 391 | 4.0E-12 | T | 22-09-2020 | IPR014012 | Helicase/SANT-associated domain |
| UnnamedSample_HQ_transcript/25427|m.8324 | UnnamedSample_HQ_transcript/25427 | Coverage 0.732 too low. | 6362e16da8cf57d95af3698163aded50 | 700 | Pfam | PF14598 | PAS domain | 369 | 473 | 9.4E-22 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/25427|m.8324 | UnnamedSample_HQ_transcript/25427 | Coverage 0.732 too low. | 6362e16da8cf57d95af3698163aded50 | 700 | Pfam | PF00010 | Helix-loop-helix DNA-binding domain | 104 | 155 | 2.4E-13 | T | 22-09-2020 | IPR011598 | Myc-type, basic helix-loop-helix (bHLH) domain |
| UnnamedSample_HQ_transcript/25427|m.8324 | UnnamedSample_HQ_transcript/25427 | Coverage 0.732 too low. | 6362e16da8cf57d95af3698163aded50 | 700 | Pfam | PF00989 | PAS fold | 179 | 281 | 2.9E-10 | T | 22-09-2020 | IPR013767 | PAS fold |
| UnnamedSample_HQ_transcript/29496|m.9355 | UnnamedSample_HQ_transcript/29496 | Coverage 0.739 too low. | 6362e16da8cf57d95af3698163aded50 | 700 | Pfam | PF14598 | PAS domain | 369 | 473 | 9.4E-22 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/29496|m.9355 | UnnamedSample_HQ_transcript/29496 | Coverage 0.739 too low. | 6362e16da8cf57d95af3698163aded50 | 700 | Pfam | PF00010 | Helix-loop-helix DNA-binding domain | 104 | 155 | 2.4E-13 | T | 22-09-2020 | IPR011598 | Myc-type, basic helix-loop-helix (bHLH) domain |
| UnnamedSample_HQ_transcript/29496|m.9355 | UnnamedSample_HQ_transcript/29496 | Coverage 0.739 too low. | 6362e16da8cf57d95af3698163aded50 | 700 | Pfam | PF00989 | PAS fold | 179 | 281 | 2.9E-10 | T | 22-09-2020 | IPR013767 | PAS fold |
| UnnamedSample_HQ_transcript/27555|m.8844 | UnnamedSample_HQ_transcript/27555 | Coverage 0.746 too low. | 6362e16da8cf57d95af3698163aded50 | 700 | Pfam | PF14598 | PAS domain | 369 | 473 | 9.4E-22 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/27555|m.8844 | UnnamedSample_HQ_transcript/27555 | Coverage 0.746 too low. | 6362e16da8cf57d95af3698163aded50 | 700 | Pfam | PF00010 | Helix-loop-helix DNA-binding domain | 104 | 155 | 2.4E-13 | T | 22-09-2020 | IPR011598 | Myc-type, basic helix-loop-helix (bHLH) domain |
| UnnamedSample_HQ_transcript/27555|m.8844 | UnnamedSample_HQ_transcript/27555 | Coverage 0.746 too low. | 6362e16da8cf57d95af3698163aded50 | 700 | Pfam | PF00989 | PAS fold | 179 | 281 | 2.9E-10 | T | 22-09-2020 | IPR013767 | PAS fold |
| UnnamedSample_HQ_transcript/41344|m.12126 | UnnamedSample_HQ_transcript/41344 | Coverage 0.983 too low. | ec072db73e1aac2e5ed66721f0e65c5e | 368 | Pfam | PF15519 | linker between RRM2 and RRM3 domains in RBM39 protein | 201 | 277 | 8.6E-22 | T | 22-09-2020 | IPR029123 | Splicing factor RBM39, linker |
| UnnamedSample_HQ_transcript/41344|m.12126 | UnnamedSample_HQ_transcript/41344 | Coverage 0.983 too low. | ec072db73e1aac2e5ed66721f0e65c5e | 368 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 15 | 80 | 1.7E-12 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/41344|m.12126 | UnnamedSample_HQ_transcript/41344 | Coverage 0.983 too low. | ec072db73e1aac2e5ed66721f0e65c5e | 368 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 113 | 182 | 2.3E-25 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/51631|m.14378 | UnnamedSample_HQ_transcript/51631 | Identity 0.916 too low. | ec072db73e1aac2e5ed66721f0e65c5e | 368 | Pfam | PF15519 | linker between RRM2 and RRM3 domains in RBM39 protein | 201 | 277 | 8.6E-22 | T | 22-09-2020 | IPR029123 | Splicing factor RBM39, linker |
| UnnamedSample_HQ_transcript/51631|m.14378 | UnnamedSample_HQ_transcript/51631 | Identity 0.916 too low. | ec072db73e1aac2e5ed66721f0e65c5e | 368 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 15 | 80 | 1.7E-12 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/51631|m.14378 | UnnamedSample_HQ_transcript/51631 | Identity 0.916 too low. | ec072db73e1aac2e5ed66721f0e65c5e | 368 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 113 | 182 | 2.3E-25 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/56934|m.15429 | UnnamedSample_HQ_transcript/56934 | Identity 0.919 too low. | ec072db73e1aac2e5ed66721f0e65c5e | 368 | Pfam | PF15519 | linker between RRM2 and RRM3 domains in RBM39 protein | 201 | 277 | 8.6E-22 | T | 22-09-2020 | IPR029123 | Splicing factor RBM39, linker |
| UnnamedSample_HQ_transcript/56934|m.15429 | UnnamedSample_HQ_transcript/56934 | Identity 0.919 too low. | ec072db73e1aac2e5ed66721f0e65c5e | 368 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 15 | 80 | 1.7E-12 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/56934|m.15429 | UnnamedSample_HQ_transcript/56934 | Identity 0.919 too low. | ec072db73e1aac2e5ed66721f0e65c5e | 368 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 113 | 182 | 2.3E-25 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/37749|m.11335 | UnnamedSample_HQ_transcript/37749 | Coverage 0.984 too low. | ec072db73e1aac2e5ed66721f0e65c5e | 368 | Pfam | PF15519 | linker between RRM2 and RRM3 domains in RBM39 protein | 201 | 277 | 8.6E-22 | T | 22-09-2020 | IPR029123 | Splicing factor RBM39, linker |
| UnnamedSample_HQ_transcript/37749|m.11335 | UnnamedSample_HQ_transcript/37749 | Coverage 0.984 too low. | ec072db73e1aac2e5ed66721f0e65c5e | 368 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 15 | 80 | 1.7E-12 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/37749|m.11335 | UnnamedSample_HQ_transcript/37749 | Coverage 0.984 too low. | ec072db73e1aac2e5ed66721f0e65c5e | 368 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 113 | 182 | 2.3E-25 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/62109|m.16470 | UnnamedSample_HQ_transcript/62109 | Identity 0.920 too low. | ec072db73e1aac2e5ed66721f0e65c5e | 368 | Pfam | PF15519 | linker between RRM2 and RRM3 domains in RBM39 protein | 201 | 277 | 8.6E-22 | T | 22-09-2020 | IPR029123 | Splicing factor RBM39, linker |
| UnnamedSample_HQ_transcript/62109|m.16470 | UnnamedSample_HQ_transcript/62109 | Identity 0.920 too low. | ec072db73e1aac2e5ed66721f0e65c5e | 368 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 15 | 80 | 1.7E-12 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/62109|m.16470 | UnnamedSample_HQ_transcript/62109 | Identity 0.920 too low. | ec072db73e1aac2e5ed66721f0e65c5e | 368 | Pfam | PF00076 | RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) | 113 | 182 | 2.3E-25 | T | 22-09-2020 | IPR000504 | RNA recognition motif domain |
| UnnamedSample_HQ_transcript/48677|m.13732 | UnnamedSample_HQ_transcript/48677 | Coverage 0.933 too low. | 1ba324454458d72a5c130825b86316e4 | 647 | Pfam | PF12660 | Putative zinc-finger of transcription factor IIIC complex | 576 | 636 | 2.5E-8 | T | 22-09-2020 | IPR024764 | Transcription factor IIIC, putative zinc-finger |
| UnnamedSample_HQ_transcript/78307|m.19428 | UnnamedSample_HQ_transcript/78307 | Coverage 0.253 too low. | 42a5cf442fc30475c54b4c725a2e1c38 | 337 | Pfam | PF04821 | Timeless protein | 2 | 88 | 4.0E-17 | T | 22-09-2020 | IPR006906 | Timeless, N-terminal |
| UnnamedSample_HQ_transcript/15162|m.5450 | UnnamedSample_HQ_transcript/15162 | Coverage 0.900 too low. | 036602a0e26f38e580636678dde244da | 1014 | Pfam | PF00122 | E1-E2 ATPase | 155 | 345 | 5.4E-43 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/15162|m.5450 | UnnamedSample_HQ_transcript/15162 | Coverage 0.900 too low. | 036602a0e26f38e580636678dde244da | 1014 | Pfam | PF00690 | Cation transporter/ATPase, N-terminus | 34 | 102 | 7.9E-17 | T | 22-09-2020 | IPR004014 | Cation-transporting P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/15162|m.5450 | UnnamedSample_HQ_transcript/15162 | Coverage 0.900 too low. | 036602a0e26f38e580636678dde244da | 1014 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 790 | 998 | 3.8E-43 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/15162|m.5450 | UnnamedSample_HQ_transcript/15162 | Coverage 0.900 too low. | 036602a0e26f38e580636678dde244da | 1014 | Pfam | PF13246 | Cation transport ATPase (P-type) | 417 | 512 | 1.3E-23 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/8356|m.3309 | UnnamedSample_HQ_transcript/8356 | Coverage 0.973 too low. | 036602a0e26f38e580636678dde244da | 1014 | Pfam | PF00122 | E1-E2 ATPase | 155 | 345 | 5.4E-43 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/8356|m.3309 | UnnamedSample_HQ_transcript/8356 | Coverage 0.973 too low. | 036602a0e26f38e580636678dde244da | 1014 | Pfam | PF00690 | Cation transporter/ATPase, N-terminus | 34 | 102 | 7.9E-17 | T | 22-09-2020 | IPR004014 | Cation-transporting P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/8356|m.3309 | UnnamedSample_HQ_transcript/8356 | Coverage 0.973 too low. | 036602a0e26f38e580636678dde244da | 1014 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 790 | 998 | 3.8E-43 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/8356|m.3309 | UnnamedSample_HQ_transcript/8356 | Coverage 0.973 too low. | 036602a0e26f38e580636678dde244da | 1014 | Pfam | PF13246 | Cation transport ATPase (P-type) | 417 | 512 | 1.3E-23 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/20387|m.6973 | UnnamedSample_HQ_transcript/20387 | Coverage 0.966 too low. | 036602a0e26f38e580636678dde244da | 1014 | Pfam | PF00122 | E1-E2 ATPase | 155 | 345 | 5.4E-43 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/20387|m.6973 | UnnamedSample_HQ_transcript/20387 | Coverage 0.966 too low. | 036602a0e26f38e580636678dde244da | 1014 | Pfam | PF00690 | Cation transporter/ATPase, N-terminus | 34 | 102 | 7.9E-17 | T | 22-09-2020 | IPR004014 | Cation-transporting P-type ATPase, N-terminal |
| UnnamedSample_HQ_transcript/20387|m.6973 | UnnamedSample_HQ_transcript/20387 | Coverage 0.966 too low. | 036602a0e26f38e580636678dde244da | 1014 | Pfam | PF00689 | Cation transporting ATPase, C-terminus | 790 | 998 | 3.8E-43 | T | 22-09-2020 | IPR006068 | Cation-transporting P-type ATPase, C-terminal |
| UnnamedSample_HQ_transcript/20387|m.6973 | UnnamedSample_HQ_transcript/20387 | Coverage 0.966 too low. | 036602a0e26f38e580636678dde244da | 1014 | Pfam | PF13246 | Cation transport ATPase (P-type) | 417 | 512 | 1.3E-23 | T | 22-09-2020 | ||
| UnnamedSample_HQ_transcript/17492|m.6155 | UnnamedSample_HQ_transcript/17492 | Coverage 0.941 too low. | 73dbbf66c74fcccba8e18b52f4d5d467 | 748 | Pfam | PF00168 | C2 domain | 11 | 117 | 3.2E-19 | T | 22-09-2020 | IPR000008 | C2 domain |
| UnnamedSample_HQ_transcript/45354|m.12994 | UnnamedSample_HQ_transcript/45354 | Coverage 0.877 too low. | 25706341f93aace9980ec3131eb2f7a0 | 369 | Pfam | PF00135 | Carboxylesterase family | 21 | 350 | 2.6E-110 | T | 22-09-2020 | IPR002018 | Carboxylesterase, type B |
| UnnamedSample_HQ_transcript/32551|m.10095 | UnnamedSample_HQ_transcript/32551 | Coverage 0.375 too low. | ff62313736b8727f2cc8e8e2e122d912 | 184 | Pfam | PF00244 | 14-3-3 protein | 12 | 141 | 1.2E-57 | T | 22-09-2020 | IPR023410 | 14-3-3 domain |
| UnnamedSample_HQ_transcript/5418|m.2340 | UnnamedSample_HQ_transcript/5418 | Coverage 0.117 too low. | ff62313736b8727f2cc8e8e2e122d912 | 184 | Pfam | PF00244 | 14-3-3 protein | 12 | 141 | 1.2E-57 | T | 22-09-2020 | IPR023410 | 14-3-3 domain |
| UnnamedSample_HQ_transcript/10676|m.4045 | UnnamedSample_HQ_transcript/10676 | Coverage 0.833 too low. | 1d7ba8c08897afdea5833e87c31ac51c | 960 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 95 | 345 | 6.8E-50 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/16563|m.5879 | UnnamedSample_HQ_transcript/16563 | Coverage 0.810 too low. | 1d7ba8c08897afdea5833e87c31ac51c | 960 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 95 | 345 | 6.8E-50 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/5722|m.2430 | UnnamedSample_HQ_transcript/5722 | Coverage 0.855 too low. | 1d7ba8c08897afdea5833e87c31ac51c | 960 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 95 | 345 | 6.8E-50 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
| UnnamedSample_HQ_transcript/8325|m.3299 | UnnamedSample_HQ_transcript/8325 | Coverage 0.922 too low. | 1d7ba8c08897afdea5833e87c31ac51c | 960 | Pfam | PF07714 | Protein tyrosine and serine/threonine kinase | 95 | 345 | 6.8E-50 | T | 22-09-2020 | IPR001245 | Serine-threonine/tyrosine-protein kinase, catalytic domain |
A
B
C
D
E
F
G
H
I
J
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
| 1. Protein accession (e.g. P51587) | |||||||||
| 2. Sequence MD5 digest (e.g. 14086411a2cdf1c4cba63020e1622579) | |||||||||
| 3. Sequence length (e.g. 3418) | |||||||||
| 4. Analysis (e.g. Pfam / PRINTS / Gene3D) | |||||||||
| 5. Signature accession (e.g. PF09103 / G3DSA:2.40.50.140) | |||||||||
| 6. Signature description (e.g. BRCA2 repeat profile) | |||||||||
| 7. Start location | |||||||||
| 8. Stop location | |||||||||
| 9. Score - is the e-value (or score) of the match reported by member database method (e.g. 3.1E-52) | |||||||||
| 10. Status - is the status of the match (T: true) | |||||||||
| 11. Date - is the date of the run | |||||||||
| 12. (InterPro annotations - accession (e.g. IPR002093) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
| 13. (InterPro annotations - description (e.g. BRCA2 repeat) - optional column; only displayed if -iprlookup option is switched on) | |||||||||
